Prestige Capital (PGEC) 10-Q 9 Nov 21 2021 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2021	Nov. 09, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2021
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--12-31
Entity File Number	000-52855
Entity Registrant Name	PRESTIGE CAPITAL CORP
Entity Central Index Key	0000790179
Entity Tax Identification Number	93-0945181
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	2157 S. Lincoln Street
Entity Address, Address Line Two	Suite 220
Entity Address, City or Town	Salt Lake City
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84106
City Area Code	801
Local Phone Number	323-3295
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	true
Entity Common Stock, Shares Outstanding		3,332,200

Condensed Balance Sheets (Unaud

Condensed Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Current Assets
Cash	$ 673	$ 4,695
Total Current Assets	673	4,695
Total Assets	673	4,695
Current Liabilities
Accounts payable - related party	10,500	6,000
Accounts payable	1,000
Accrued interest - related party	60,592	49,947
Notes payable - related party	188,515	180,515
Total Current Liabilities	260,607	236,462
Total Liabilities	260,607	236,462
Stockholders' Deficit
Preferred stock - 10,000,000 shares authorized - None issued and outstanding
Common stock - 100,000,000 shares authorized having a par value of $0.001 per share, 3,332,200 shares issued and outstanding	3,332	3,332
Additional paid in capital	713,573	713,573
Accumulated deficit	(976,839)	(948,672)
Total Stockholders' Deficit	(259,934)	(231,767)
Total Liabilities and Stockholders' Deficit	$ 673	$ 4,695

Condensed Balance Sheets (Una_2

Condensed Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares authorized	100,000,000	100,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	3,332,200	3,332,200
Common stock, shares outstanding	3,332,200	3,332,200

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Revenues
Operating Expenses
General and administrative	8,313	2,724	17,522	10,872
Loss from Operations	(8,313)	(2,724)	(17,522)	(10,872)
Other Income (Expense)
Interest expense - related party	(3,399)	(3,342)	(10,645)	(9,860)
Total Other Income (Expense)	(3,399)	(3,342)	(10,645)	(9,860)
Loss before income taxes	(11,712)	(6,066)	(28,167)	(20,732)
Income tax expense
Net Loss	$ (11,712)	$ (6,066)	$ (28,167)	$ (20,732)
Basic and Diluted Loss Per Share	$ 0	$ 0	$ (0.01)	$ (0.01)
Basic and Diluted Weighted Average Number of Common Shares Outstanding	3,332,200	3,332,200	3,332,200	3,332,200

Condensed Statements of Stockho

Condensed Statements of Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
at Dec. 31, 2019	$ 3,332	$ 713,573	$ (921,761)	$ (204,856)
Beginning balance, shares at Dec. 31, 2019	3,332,200
			(8,642)	(8,642)
at Mar. 31, 2020	$ 3,332	713,573	(930,403)	(213,498)
Ending balance, shares at Mar. 31, 2020	3,332,200
at Dec. 31, 2019	$ 3,332	713,573	(921,761)	(204,856)
Beginning balance, shares at Dec. 31, 2019	3,332,200
				(20,732)
at Sep. 30, 2020	$ 3,332	713,573	(942,493)	(225,588)
Ending balance, shares at Sep. 30, 2020	3,332,200
at Mar. 31, 2020	$ 3,332	713,573	(930,403)	(213,498)
Beginning balance, shares at Mar. 31, 2020	3,332,200
			(6,024)	(6,024)
at Jun. 30, 2020	$ 3,332	713,573	(936,427)	(219,522)
Ending balance, shares at Jun. 30, 2020	3,332,200
			(6,066)	(6,066)
at Sep. 30, 2020	$ 3,332	713,573	(942,493)	(225,588)
Ending balance, shares at Sep. 30, 2020	3,332,200
at Dec. 31, 2020	$ 3,332	713,573	(948,672)	(231,767)
Beginning balance, shares at Dec. 31, 2020	3,332,200
			(9,019)	(9,019)
at Mar. 31, 2021	$ 3,332	713,573	(957,691)	(240,786)
Ending balance, shares at Mar. 31, 2021	3,332,200
at Dec. 31, 2020	$ 3,332	713,573	(948,672)	(231,767)
Beginning balance, shares at Dec. 31, 2020	3,332,200
				(28,167)
at Sep. 30, 2021	$ 3,332	713,573	(976,839)	(259,934)
Ending balance, shares at Sep. 30, 2021	3,332,200
at Mar. 31, 2021	$ 3,332	713,573	(957,691)	(240,786)
Beginning balance, shares at Mar. 31, 2021	3,332,200
			(7,436)	(7,436)
at Jun. 30, 2021	$ 3,332	713,573	(965,127)	(248,222)
Ending balance, shares at Jun. 30, 2021	3,332,200
			(11,712)	(11,712)
at Sep. 30, 2021	$ 3,332	$ 713,573	$ (976,839)	$ (259,934)
Ending balance, shares at Sep. 30, 2021	3,332,200

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (28,167)	$ (20,732)
Adjustments to reconcile net loss to net cash used in operating activities:
Expenses paid by related party	4,500	4,500
Changes in operating assets and liabilities
Increase (decrease) in accounts payable	1,000	(1,200)
Increase in accrued interest - related party	10,645	9,860
Net cash used in operating activities	(12,022)	(7,572)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable - related party	8,000	8,400
Net cash provided by financing activities	8,000	8,400
Net Increase (Decrease) in Cash	(4,022)	828
Beginning Cash Balance	4,695	105
Ending Cash Balance	673	933
Supplemental Disclosures
Interest expense
Income taxes

NOTE 1 - CONDENSED FINANCIAL ST

NOTE 1 - CONDENSED FINANCIAL STATEMENTS	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NOTE 1 - CONDENSED FINANCIAL STATEMENTS	NOTE 1 - CONDENSED FINANCIAL STATEMENTS The accompanying financial statements have been prepared by the Company without audit. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows as of, and for, the period ended September 30, 2021 and for all periods presented have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the financial statements and notes thereto included in the Company's December 31, 2020 audited financial statements as reported in its Form 10-K. The results of operations for the nine-month period ended September 30, 2021 are not necessarily indicative of the operating results for the full year ended December 31, 2021.

NOTE 2 - GOING CONCERN

NOTE 2 - GOING CONCERN	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NOTE 2 - GOING CONCERN	NOTE 2 - GOING CONCERN The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has limited assets, has incurred losses since inception, has negative cash flows from operations, and has no revenue-generating activities. Its activities have been limited for the past several years and it is dependent upon financing to continue operations. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. It is management's plan to acquire or merge with other operating companies. The COVID-19 pandemic could have an impact on our ability to obtain financing to fund our operations. The Company is unable to predict the ultimate impact at this time.

NOTE 3 - NOTES PAYABLE

NOTE 3 - NOTES PAYABLE	9 Months Ended
	Sep. 30, 2021
Debt Disclosure [Abstract]
NOTE 3 - NOTES PAYABLE	NOTE 3 - NOTES PAYABLE During the nine months ended September 30, 2021 and 2020, the Company borrowed $ 8,000 8,400 188,515 180,515 8 10,645 9,860 60,592 49,947 During the nine months ended September 30, 2021 and 2020, a shareholder invoiced the Company for consulting, administrative and professional services and out-of-pocket costs provided or paid on behalf of the Company totaling $ 4,500 4,500

NOTE 4 - SUBSEQUENT EVENTS

NOTE 4 - SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
NOTE 4 - SUBSEQUENT EVENTS	NOTE 4 - SUBSEQUENT EVENTS The Company's management reviewed all material events through the date of this filing and has determined that there are no material subsequent events to report.

NOTE 3 - NOTES PAYABLE (Details

NOTE 3 - NOTES PAYABLE (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Debt Disclosure [Abstract]
Amounts borrowed from a shareholder	$ 8,000	$ 8,400
Notes payable - related party balance	$ 188,515		$ 180,515
Interest rate on loans	8.00%	8.00%
Interest expense on loans	$ 10,645	$ 9,860
Accrued interest on loans	60,592		$ 49,947
Expenses paid by related party	$ 4,500	$ 4,500